Izuo, N., Kasahara, C., Murakami, K., Kume, T., Maeda, M., Irie, K., . . . Shimizu, T. (2017). A Toxic Conformer of Aβ42 with a Turn at 22–23 is a Novel Therapeutic Target for Alzheimer’s Disease. Sci Rep.
Chicago Style CitationIzuo, Naotaka, Chihiro Kasahara, Kazuma Murakami, Toshiaki Kume, Masahiro Maeda, Kazuhiro Irie, Koutaro Yokote, and Takahiko Shimizu. "A Toxic Conformer of Aβ42 With a Turn At 22–23 Is a Novel Therapeutic Target for Alzheimer’s Disease." Sci Rep 2017.
MLA CitationIzuo, Naotaka, et al. "A Toxic Conformer of Aβ42 With a Turn At 22–23 Is a Novel Therapeutic Target for Alzheimer’s Disease." Sci Rep 2017.
Warning: These citations may not always be 100% accurate.